C

Celea Therapeutics

Clinical-stage biopharma developing deupirfenidone for IPF

Associate Director/Senior Manager, Clinical Compliance Specialist

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeBoston, MA, USA

About the Job

Requirements

  • A bachelor's degree in Life Sciences, Nursing, Health Sciences, Pharmacy, or a related field is required.
  • Three to seven years of experience in clinical research, clinical operations, quality assurance, or clinical compliance is required.
  • Experience working in pharmaceutical, biotechnology, medical device, or contract research organization environments is required.
  • Knowledge of global clinical trial regulations and compliance requirements, with the ability to translate requirements into practical operational guidance, is required.
  • Experience supporting standard operating procedure development and quality system processes is required.
  • Working knowledge of the clinical trial lifecycle and study execution, including site management, monitoring, trial master file requirements, and vendor oversight, is required.
  • Familiarity with audit and inspection activities is required.
  • Strong organizational and documentation skills are required.
  • Strong training and presentation capabilities are required.

Responsibilities

  • Ensure compliance with Good Clinical Practice, International Council for Harmonisation, U.S. Food and Drug Administration, European Medicines Agency, and other applicable regulations across clinical development programs, and serve as a compliance resource to Clinical Operations teams during study startup, conduct, and closeout.
  • Monitor and assess clinical trial processes and documentation, identifying, evaluating, and escalating compliance risks, deviations, and inspection-readiness concerns.
  • Assist study teams in identifying and resolving operational compliance issues, and support implementation of corrective and preventive actions and continuous compliance improvement initiatives.
  • Develop, maintain, periodically review, and update clinical standard operating procedures, work instructions, templates, and guidance documents to align with current regulations, industry standards, and organizational needs.
  • Partner with cross-functional teams to enhance quality systems and operational processes, track standard operating procedure training completion, and maintain compliance records.
  • Support internal audits, vendor audits, and regulatory inspections.
  • Support quality management system activities and continuous improvement initiatives.

Desired Qualifications

  • An advanced degree is preferred.
  • Certified Clinical Research Professional, Certified Clinical Research Associate, or equivalent certification is preferred.
  • Experience supporting regulatory inspections involving the U.S. Food and Drug Administration, European Medicines Agency, Medicines and Healthcare products Regulatory Agency, Pharmaceuticals and Medical Devices Agency, or other health authorities is preferred.
  • Experience with electronic quality management systems, document management systems, and clinical trial systems is preferred.
  • Knowledge of risk-based quality management principles is preferred.
  • Experience working with global clinical trials and outsourced service providers is preferred.

About the Company

Celea Therapeutics

Clinical-stage biopharma developing deupirfenidone for IPF

Celea Therapeutics develops and advances treatments for severe respiratory diseases, focusing on late-stage development of deupirfenidone (LYT-100), a deuterated form of pirfenidone. Its lead program targets idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases and is prepared for Phase 3 trials. Deupirfenidone aims to slow lung function decline and improve tolerability by changing how the drug is processed in the body, potentially offering advantages over current IPF therapies. The company pursues a Phase 3 head-to-head trial (SURPASS-IPF) against an approved therapy, supported by Orphan Drug Designations and funding from investors, with PureTech Health retaining a meaningful stake.

Company size
11-50
Company stage
Growth Equity (Non-Venture Capital)
Total funding
$180M
Headquarters
Boston, MA
Founded
Not listed

Recently Posted Jobs

Explore more opportunities at Celea Therapeutics

See more jobs